Suppr超能文献

相似文献

4
Differential inhibition of human CYP3A4 and Candida albicans CYP51 with azole antifungal agents.
Chem Biol Interact. 2000 Mar 15;125(3):165-75. doi: 10.1016/s0009-2797(99)00169-6.
5
Differential inhibition of Candida albicans CYP51 with azole antifungal stereoisomers.
FEMS Microbiol Lett. 1997 Apr 1;149(1):25-30. doi: 10.1111/j.1574-6968.1997.tb10303.x.
9
Comparison of lanosterol-14 alpha-demethylase (CYP51) of human and Candida albicans for inhibition by different antifungal azoles.
Toxicology. 2006 Nov 10;228(1):24-32. doi: 10.1016/j.tox.2006.08.007. Epub 2006 Aug 12.
10
Azole binding properties of Candida albicans sterol 14-alpha demethylase (CaCYP51).
Antimicrob Agents Chemother. 2010 Oct;54(10):4235-45. doi: 10.1128/AAC.00587-10. Epub 2010 Jul 12.

引用本文的文献

1
Approaches for identifying and measuring heteroresistance in azole-susceptible isolates.
Microbiol Spectr. 2024 Apr 2;12(4):e0404123. doi: 10.1128/spectrum.04041-23. Epub 2024 Mar 14.
2
An expanded toolkit of drug resistance cassettes for , , and leads to new insights into the ergosterol pathway.
mSphere. 2023 Dec 20;8(6):e0031123. doi: 10.1128/msphere.00311-23. Epub 2023 Nov 6.
3
Evaluation of Antifungal Selective Toxicity Using and Human Knock-In Strains.
J Fungi (Basel). 2023 Oct 20;9(10):1035. doi: 10.3390/jof9101035.
4
Superficial Dermatophytosis across the World's Populations: Potential Benefits from Nanocarrier-Based Therapies and Rising Challenges.
ACS Omega. 2023 Aug 22;8(35):31575-31599. doi: 10.1021/acsomega.3c01988. eCollection 2023 Sep 5.
5
Small molecules restore azole activity against drug-tolerant and drug-resistant isolates.
mBio. 2023 Aug 31;14(4):e0047923. doi: 10.1128/mbio.00479-23. Epub 2023 Jun 16.
6
Fungal Drug Response and Antimicrobial Resistance.
J Fungi (Basel). 2023 May 12;9(5):565. doi: 10.3390/jof9050565.
7
Recent drug development and treatments for fungal infections.
Braz J Microbiol. 2023 Sep;54(3):1695-1716. doi: 10.1007/s42770-023-00999-z. Epub 2023 May 23.
8
Review of Recurrent Otomycosis and Clotrimazole in Its Treatment.
Cureus. 2022 Oct 9;14(10):e30098. doi: 10.7759/cureus.30098. eCollection 2022 Oct.
9
Effect of Topical Antifungal Luliconazole on Hyphal Morphology of Trichophyton mentagrophytes Grown on in vitro Onychomycosis Model.
Mycopathologia. 2022 Dec;187(5-6):491-496. doi: 10.1007/s11046-022-00661-6. Epub 2022 Sep 3.

本文引用的文献

3
Inhibition of sterol C14 demethylation by imidazole-containing antifungals.
Sabouraudia. 1982 Dec;20(4):325-9. doi: 10.1080/00362178285380461.
5
Buthiobate: a potent inhibitor for yeast cytochrome P-450 catalyzing 14 alpha-demethylation of lanosterol.
Biochem Biophys Res Commun. 1983 Sep 15;115(2):642-7. doi: 10.1016/s0006-291x(83)80192-2.
7
Biochemical targets for antifungal azole derivatives: hypothesis on the mode of action.
Curr Top Med Mycol. 1985;1:313-51. doi: 10.1007/978-1-4613-9547-8_12.
9
Interaction of azole antifungal agents with cytochrome P-45014DM purified from Saccharomyces cerevisiae microsomes.
Biochem Pharmacol. 1987 Jan 15;36(2):229-35. doi: 10.1016/0006-2952(87)90694-0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验